Problem

Voize addresses the administrative burden of nursing documentation in skilled-nursing, long-term-care, and elder-care settings. Nurses may individually enter 600–800 data points into an EHR per shift, while poor EHR usability and documentation burden contribute to dissatisfaction. The operational cost is substantial: delayed charting creates overtime, increases compliance and reimbursement risk, and takes caregivers away from residents. The killer use case is point-of-care documentation after medication administration or other care, replacing end-of-shift catch-up charting with immediate voice capture.

Product / Service

Voize is a purpose-built AI voice-documentation app for nurses and caregivers. Staff speak naturally into a phone during or immediately after care; the system recognizes nursing terminology, structures and categorizes the speech, and transfers the resulting entries into the facility’s existing EHR in real time. It supports offline use, bi-directional EHR integration, and workflows such as medication documentation, vital signs, admissions, and shift handoffs.

The benefit is faster, more complete documentation without stationary charting, handwritten notes, double entry, or reliance on memory. Voize positions itself as an AI companion rather than a replacement for care: by reducing paperwork and overtime, it aims to return nurses’ time to residents and improve compliance and reimbursement accuracy.

Market

Voize competes in the healthcare AI-scribe and voice-enabled clinical-documentation market, with a focused wedge in skilled nursing and long-term care rather than general-purpose physician dictation. Adjacent AI medical-scribe offerings include Freed, Heidi, Abridge, DAX, and Suki, although the available evidence presents these as broader medical-scribe alternatives rather than confirmed direct competitors in Voize’s nursing-home niche.

The company is clearly beyond a pre-revenue or purely pilot stage: it reported adoption across more than 600 facilities in March 2025, while its current company profile says more than 1,500 care facilities and over 100,000 nurses rely on the product. Voize raised a $9 million seed round in March 2025 and a $50 million Series A led by Balderton Capital in November 2025 to expand across Europe and enter the United States. Public sources do not disclose revenue, pricing, or retention-adjusted financials, but the facility and user counts indicate meaningful commercial traction.